The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency implications and potential sources of bias

摘要

BackgroundInterim analysis of accumulating trial data is important to protect participant safety during randomized controlled trials (RCTs). Data Monitoring Committees (DMCs) often undertake such analyses, but their widening role may lead to extended use of interim analysis or recommendations that could potentially bias trial results.